{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Atherosclerosis", "Endothelial cells", "Inflammation"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36212750", "DateRevised": {"Year": "2022", "Month": "10", "Day": "11"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "09", "Day": "15"}], "Language": ["eng"], "ELocationID": ["10.12997/jla.2022.11.3.272"], "Journal": {"ISSN": "2287-2892", "JournalIssue": {"Volume": "11", "Issue": "3", "PubDate": {"Year": "2022", "Month": "Sep"}}, "Title": "Journal of lipid and atherosclerosis", "ISOAbbreviation": "J Lipid Atheroscler"}, "ArticleTitle": "Shinjulactone A Blocks Vascular Inflammation and the Endothelial-Mesenchymal Transition.", "Pagination": {"StartPage": "272", "EndPage": "279", "MedlinePgn": "272-279"}, "Abstract": {"AbstractText": ["The endothelial inflammatory response plays an important role in atherogenesis by inducing nuclear factor (NF)\u03baB-dependent cell adhesion molecule expression and monocyte recruitment. Here, we screened for natural ligands and investigated the ability of shinjulactone A to inhibit interleukin-1\u03b2 (IL-1\u03b2)-induced endothelial inflammatory signaling.", "The natural compound library included 880 single compounds isolated from medicinal plants by the Korean Medicinal Material Bank. Primary endothelial cells were pretreated with single compounds before stimulation with IL-1\u03b2 to induce endothelial inflammation. Endothelial inflammation was measured by assaying NF\u03baB activation and monocyte adhesion. The endothelial-mesenchymal transition (EndMT) was evaluated using cell type-specific marker protein expression and morphology.", "Shinjulactone A was identified as an efficient blocker of IL-1\u03b2 -induced NF\u03baB activation, with a half-maximal inhibitory concentration of approximately 1 \u00b5M, and monocyte recruitment in endothelial cells. However, it did not affect lipopolysaccharide-induced NF\u03baB activation in macrophages. Compared to Bay 11-782, a well-known NF\u03baB inhibitor that shows considerable cytotoxicity during long-term treatment, shinjulactone A did not affect endothelial cell viability. Furthermore, it also significantly inhibited the EndMT, which is known to promote atherosclerosis and plaque instability.", "We suggest that shinjulactone A may be an effective and safe drug candidate for atherosclerosis because it targets and inhibits both endothelial inflammation and the EndMT, without impairing NF\u03baB-dependent innate immunity in macrophages."], "CopyrightInformation": "Copyright \u00a9 2022 The Korean Society of Lipid and Atherosclerosis."}, "AuthorList": [{"Identifier": ["0000-0003-3282-3151"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Inje University, Gimhae, Korea."}], "LastName": "Jang", "ForeName": "Ye-Eun", "Initials": "YE"}, {"Identifier": ["0000-0002-7236-1855"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Inje University, Gimhae, Korea."}], "LastName": "Immanuel", "ForeName": "Jenita", "Initials": "J"}, {"Identifier": ["0000-0003-0322-8177"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Inje University, Gimhae, Korea."}], "LastName": "Lee", "ForeName": "Jin-Ri", "Initials": "JR"}, {"Identifier": ["0000-0003-3787-2809"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Inje University, Gimhae, Korea."}], "LastName": "Jang", "ForeName": "Yu-Jin", "Initials": "YJ"}, {"Identifier": ["0000-0001-7898-9814"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National Institute of Korean Medicine Development, Gyeongsan, Korea."}], "LastName": "Kwon", "ForeName": "Yun Ju", "Initials": "YJ"}, {"Identifier": ["0000-0002-8045-1543"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National Institute of Korean Medicine Development, Gyeongsan, Korea."}], "LastName": "Kwon", "ForeName": "Hyun Sook", "Initials": "HS"}, {"Identifier": ["0000-0003-1047-9871"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedical Engineering, Inje University, Gimhae, Korea."}], "LastName": "Shin", "ForeName": "Jung-Woog", "Initials": "JW"}, {"Identifier": ["0000-0002-3926-1473"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Inje University, Gimhae, Korea."}], "LastName": "Yun", "ForeName": "Sanguk", "Initials": "S"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Korea (South)", "MedlineTA": "J Lipid Atheroscler", "NlmUniqueID": "101610890", "ISSNLinking": "2287-2892"}, "CoiStatement": "Conflict of Interest: The authors have no conflicts of interest to declare."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Wu MY, Li CJ, Hou MF, Chu PY. New insights into the role of inflammation in the pathogenesis of atherosclerosis. Int J Mol Sci. 2017;18:2034.", "ArticleIdList": ["PMC5666716", "28937652"]}, {"Citation": "Hu W, Zhang Q, Yang X, Wang Y, Sun L. Puerarin inhibits adhesion molecule expression in tnf-\u03b1-stimulated human endothelial cells via modulation of the nuclear factor kappaB pathway. Pharmacology. 2010;85:27\u201335.", "ArticleIdList": ["20016245"]}, {"Citation": "Gareus R, Kotsaki E, Xanthoulea S, van der Made I, Gijbels MJ, Kardakaris R, et al. Endothelial cell-specific NF-kappaB inhibition protects mice from atherosclerosis. Cell Metab. 2008;8:372\u2013383.", "ArticleIdList": ["19046569"]}, {"Citation": "Kirii H, Niwa T, Yamada Y, Wada H, Saito K, Iwakura Y, et al. Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol. 2003;23:656\u2013660.", "ArticleIdList": ["12615675"]}, {"Citation": "Libby P. Interleukin-1 beta as a target for atherosclerosis therapy: biological basis of CANTOS and beyond. J Am Coll Cardiol. 2017;70:2278\u20132289.", "ArticleIdList": ["PMC5687846", "29073957"]}, {"Citation": "Gualtieri P, Marchetti M, Cioccoloni G, De Lorenzo A, Romano L, Cammarano A, et al. Psychobiotics regulate the anxiety symptoms in carriers of allele A of IL-1\u03b2 gene: a randomized, placebo-controlled clinical trial. Mediators Inflamm. 2020;2020:2346126.", "ArticleIdList": ["PMC7199572", "32377159"]}, {"Citation": "Souilhol C, Harmsen MC, Evans PC, Krenning G. Endothelial-mesenchymal transition in atherosclerosis. Cardiovasc Res. 2018;114:565\u2013577.", "ArticleIdList": ["29309526"]}, {"Citation": "Jackson AO, Zhang J, Jiang Z, Yin K. Endothelial-to-mesenchymal transition: A novel therapeutic target for cardiovascular diseases. Trends Cardiovasc Med. 2017;27:383\u2013393.", "ArticleIdList": ["28438397"]}, {"Citation": "Rieder F, Kessler SP, West GA, Bhilocha S, de la Motte C, Sadler TM, et al. Inflammation-induced endothelial-to-mesenchymal transition: a novel mechanism of intestinal fibrosis. Am J Pathol. 2011;179:2660\u20132673.", "ArticleIdList": ["PMC3204019", "21945322"]}, {"Citation": "Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol. 2007;7:678\u2013689.", "ArticleIdList": ["17717539"]}, {"Citation": "Deshpande R, Khalili H, Pergolizzi RG, Michael SD, Chang MD. Estradiol down-regulates LPS-induced cytokine production and NFkB activation in murine macrophages. Am J Reprod Immunol. 1997;38:46\u201354.", "ArticleIdList": ["9266010"]}, {"Citation": "De Martino L, De Feo V. Chemistry and biological activities of Ailanthus altissima Swingle: a review. Pharmacogn Rev. 2008;2:339\u2013350."}, {"Citation": "Fiaschetti G, Grotzer MA, Shalaby T, Castelletti D, Arcaro A. Quassinoids: From traditional drugs to new cancer therapeutics. Curr Med Chem. 2011;18:316\u2013328.", "ArticleIdList": ["21143123"]}, {"Citation": "van Diepen JA, Berb\u00e9e JF, Havekes LM, Rensen PC. Interactions between inflammation and lipid metabolism: relevance for efficacy of anti-inflammatory drugs in the treatment of atherosclerosis. Atherosclerosis. 2013;228:306\u2013315.", "ArticleIdList": ["23518178"]}, {"Citation": "Sima AV, Stancu CS, Simionescu M. Vascular endothelium in atherosclerosis. Cell Tissue Res. 2009;335:191\u2013203.", "ArticleIdList": ["18797930"]}, {"Citation": "Yu XH, Zheng XL, Tang CK. Nuclear factor-\u03baB activation as a pathological mechanism of lipid metabolism and atherosclerosis. Adv Clin Chem. 2015;70:1\u201330.", "ArticleIdList": ["26231484"]}, {"Citation": "Lawrence T, Fong C. The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Biol. 2010;42:519\u2013523.", "ArticleIdList": ["20026420"]}, {"Citation": "S\u00e1nchez-Duffhues G, Garc\u00eda de Vinuesa A, Ten Dijke P. Endothelial-to-mesenchymal transition in cardiovascular diseases: developmental signaling pathways gone awry. Dev Dyn. 2018;247:492\u2013508.", "ArticleIdList": ["28891150"]}, {"Citation": "Libby P. Inflammatory mechanisms: the molecular basis of inflammation and disease. Nutr Rev. 2007;65:S140\u2013S146.", "ArticleIdList": ["18240538"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "6", "Day": "20"}, {"Year": "2022", "Month": "7", "Day": "25"}, {"Year": "2022", "Month": "10", "Day": "10", "Hour": "4", "Minute": "18"}, {"Year": "2022", "Month": "10", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "10", "Day": "11", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "9", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["36212750", "PMC9515731", "10.12997/jla.2022.11.3.272"]}}], "PubmedBookArticle": []}